Zheng GL, Zhang B, Wang Y, Liu Y, Zhu HT, Zhao Y, Zheng ZC. Surgical resection of esophagogastric junction stromal tumor: How to protect the cardiac function. World J Gastroenterol 2021; 27(9): 854-865 [PMID: 33727774 DOI: 10.3748/wjg.v27.i9.854]
Corresponding Author of This Article
Zhi-Chao Zheng, MD, PhD, Chief Doctor, Professor, Department of Gastric Surgery, Cancer Hospital of China Medical University (Liaoning Cancer Hospital and Institute), No. 44 Xiaoheyan Road, Shenyang 110042, Liaoning Province, China. drzhengzc@126.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Mar 7, 2021; 27(9): 854-865 Published online Mar 7, 2021. doi: 10.3748/wjg.v27.i9.854
Table 1 Comparison of clinical and pathologic variables of study patients
Variables
CR group
PG group
P value
Age, median (range), in yr
58 (32-73)
61 (28-75)
0.532
Sex
0.168
Male
8
16
Female
10
9
Size in cm
0.549
≤ 2
1
0
2.1-5.0
6
6
5.1-10
7
13
> 10
4
6
Histologic type
0.71
Spindle
13
18
Epitheloid
1
3
Mixed
4
4
Mitotic index, per 50 HPF
0.766
≤ 5
13
17
> 5
5
8
Ki-67
0.163
≤ 5%
15
16
> 5%
3
9
CD117
0.929
Positive
16
22
Negative
2
3
CD34
0.159
Positive
15
24
Negative
3
1
DOG-1
0.083
Positive
13
23
Negative
5
2
NIH risk category
0.476
Very low risk
1
0
Low risk
5
4
Intermediate risk
7
12
High risk
5
9
Length of the upper edge of the GIST crossing the Z-line, mean ± SD (cm)
0.639 (0.29)
1.024 (0.395)
0.193
Circumference of the EGJ involvement
0.716
T ≤ 1/4
10
13
1/4 < T ≤ 2/4
7
8
2/4 < T ≤ 3/4
1
3
T > 3/4
0
1
Heartburn, postoperative
Yes
3
16
0.004
No
15
9
Oral antacids, postoperative
Yes
4
18
0.002
No
14
7
Table 2 Comparison of intra-operative and postoperative variables between two surgical procedures for type A esophagogastric junction-gastrointestinal stromal tumors
CR group, n = 18
PG group, n = 25
P value
95%CI
Lower
Upper
Operating time in min
108.61 ± 30.13
137.80 ± 51.04
0.029
-56.41
-0.97
Intraoperative blood loss in mL
59.44 ± 23.08
90.60 ± 35.62
0.069
-53.53
-11.78
First passage of flatus time in h
29.11 ± 15.35
74.24 ± 40.39
0.013
-65.389
-24.87
Days to oral intake
3.56 ± 1.65
8.68 ± 3.88
0.006
-7.09
-3.16
Postoperative hospital stay in d
6.00 ± 2.40
10.96 ± 4.15
0.049
-7.17
-2.75
Negative margin, %
100
100
Table 3 Postoperative esophageal 24-h pH parameters of patients who underwent surgery for type A esophagogastric junction-gastrointestinal stromal tumors
Mean 24-h pH
Total time for pH < 4 (min)
Acid reflux number of 24 h
Regurgitation events, > 5 min
Standing
Lying
CR group, n = 18
4.97 ± 1.44
31.83 ± 22.65
17.83 ± 11.25
35.62 ± 15.71
1.44 ± 1.68
PG group, n = 25
3.41 ± 1.15
184.48 ± 118.74
32.68 ± 15.89
58.81 ± 19.13
6.04 ± 1.92
P value
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
Table 4 Postoperative health-related quality of life of study patients
PF
RP
BP
GH
VT
SF
RE
MH
CR group, n = 18
53.72 ± 2.13
54.61 ± 1.61
60.94 ± 1.86
61.56 ± 1.75
61.72 ± 3.49
55.11 ± 2.24
50.61 ± 2.93
55.00 ± 2.27
PG group, n = 25
48.00 ± 3.64
48.36 ± 2.89
49.80 ± 4.12
50.72 ± 5.15
52.20 ± 4.06
44.60 ± 2.63
37.16 ± 4.08
46.12 ± 3.95
P value
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
Citation: Zheng GL, Zhang B, Wang Y, Liu Y, Zhu HT, Zhao Y, Zheng ZC. Surgical resection of esophagogastric junction stromal tumor: How to protect the cardiac function. World J Gastroenterol 2021; 27(9): 854-865